Information Provided By:
Fly News Breaks for December 10, 2019
Dec 10, 2019 | 06:55 EDT
Citi analyst Ralph Giacobbe raised his price target for Surgery Partners to $20 from $13 and keeps a Buy rating on the shares after hosting investor meetings with management. The combination of hitting Q4 consensus estimates and a long-term "favorable structural story," together with a high short interest, sets the company up for potential multiple expansion, Giacobbe tells investors in a research note.
News For SGRY From the Last 2 Days
There are no results for your query SGRY